A wave of lawsuits involving the antibiotics Levaquin, Cipro and Avelox are bring filed by people throughout the U.S. who have been diagnosed with peripheral neuropathy after using one of the popular antibiotics
There are currently at least 59 peripheral neuropathy suits filed against makers of the antibiotics, which is more than double the number reported only eight weeks ago. Levaquin, Avelox and Cipro are all antibiotics that are part of the same class of medications, known as fluoroquinolones, which have been linked to reports of permanent and debilitating nerve damage that may cause individuals to experience problems for years after they stop using the medications.
The U.S. Judicial Panel on Multidistrict Litigation (JPML) is scheduled to hear oral arguments on a motion to establish an antibiotic peripheral neuropathy MDL during a session in San Francisco on July 30. There is another grouping of such suits before U.S. District Judge David R. Herndon in the Southern District of Illinois, to reduce duplicative discovery into common issues, avoid conflicting pretrial rulings from different courts and to serve the convenience of the parties, witnesses and the courts.